C
Con Kelleher
Researcher at St Thomas' Hospital
Publications - 55
Citations - 5682
Con Kelleher is an academic researcher from St Thomas' Hospital. The author has contributed to research in topics: Overactive bladder & Urinary incontinence. The author has an hindex of 25, co-authored 55 publications receiving 5145 citations. Previous affiliations of Con Kelleher include Guy's Hospital.
Papers
More filters
Journal ArticleDOI
Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC Study
Debra E. Irwin,Ian Milsom,Steinar Hunskaar,Kate Reilly,Zoe Kopp,Sender Herschorn,Karin S. Coyne,Con Kelleher,Christian Hampel,Walter Artibani,Paul Abrams +10 more
TL;DR: The EPIC study is the largest population-based survey to assess prevalence rates of OAB, UI, and other LUTS in five countries and is the first study to evaluate these symptoms simultaneously using the 2002 ICS definitions.
Journal ArticleDOI
The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.
TL;DR: To examine the effect overactive bladder (OAB) and other lower urinary tract symptoms (LUTS) on health‐related quality of life (HRQoL) in a population sample, as OAB often occurs in conjunction with many other LUTS.
Journal Article
Overactive bladder significantly affects quality of life.
TL;DR: Overactive bladder (OAB), with symptoms of frequency, urgency, and urge incontinence, substantially affects the lives of millions of people and remains underreported, despite increased awareness and improved diagnosis and treatment.
Journal ArticleDOI
Combination treatment with mirabegron and solifenacin in patients with overactive bladder: efficacy and safety results from a randomised, double-blind, dose-ranging, phase 2 study (Symphony).
Paul Abrams,Con Kelleher,David R. Staskin,Tomasz Rechberger,Richard Kay,Reynaldo Martina,Donald Newgreen,Asha Paireddy,Rob van Maanen,Arwin Ridder +9 more
TL;DR: Combination therapy improved OAB symptoms and had similar safety and acceptability and all combinations were well tolerated, with no important additional safety findings compared with monotherapy or placebo.
Journal ArticleDOI
The current and future burden and cost of overactive bladder in five European countries.
TL;DR: OAB is prevalent, with a substantial direct cost that is anticipated to increase in the future in line with aging populations, and the overall burden may be considerably larger, and will fall predominantly on the elderly OAB population with urge incontinence.